Arachidonic acid can significantly prevent early insulin resistance induced by a high-fat diet

Annals of Nutrition and Metabolism

Volumn 51, Issue 3, 2007, Pages 270-276

  Wu, Mianyun ^a,b   Wang, Ximing ^a   Duan, Qiuhong ^a   Lu, Tao ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b WUHAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Arachidonic acid; Glucose 6 phosphatase; Glycogen; Insulin resistance; Oral glucose tolerance test; Phosphoenolpyruvate carboxykinase

Indexed keywords

ARACHIDONIC ACID; GLUCOSE 6 PHOSPHATASE; GLYCOGEN; INSULIN; MESSENGER RNA; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; GLYCOGEN LIVER LEVEL; HYPERINSULINEMIA; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID DIET; MALE; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; RAT; STATISTICAL ANALYSIS; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALS; ARACHIDONIC ACID; BLOOD GLUCOSE; DIETARY FATS; GENE EXPRESSION REGULATION; GLUCOSE TOLERANCE TEST; GLUCOSE-6-PHOSPHATASE; INSULIN; INSULIN RESISTANCE; LIVER; LIVER GLYCOGEN; MALE; PHOSPHOENOLPYRUVATE CARBOXYKINASE (ATP); RANDOM ALLOCATION; RATS; RATS, WISTAR; TRIGLYCERIDES;

RATTUS; RATTUS NORVEGICUS;

EID: 34548101725     PISSN: 02506807     EISSN: None     Source Type: Journal    
DOI: 10.1159/000105448     Document Type: Article

References (30)

1. Fukuchi S, Hamaguchi K, Seike M, Himeno K, Sakata T, Yoshimatsu H: Role of fatty acid composition in the development of metabolic disorders in sucrose-induced obese rats. Exp Biol Med 2004;229:486-493.
2. Das UN: Essential fatty acid metabolism in patients with essential hypertension, diabetes mellitus and coronary heart disease. Prostaglandins Leukot Essent Fatty Acids 1995;52:387-391.
3. Rosenthal MJ, Hwang IK, Song MK: Effects of arachidonic acid and cyclo (his-pro) on zinc transport across small intestine and muscle tissues. Life Sci 2001;70:337-348.
4. Moon B, Kwan JJ, Duddy N, Sweeney G, Begum N: Resistin inhibits glucose uptake in L6 cells independently of changes in insulin signaling and GLUT4 translocation. Am J Physiol Endocrinol Metab 2003;285:106-115.
5. Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, Patel HR, Ahima RS, Lazar MA: The hormone resistin links obesity to diabetes. Nature 2001;409:307-312.
6. Wan X, Wang X, Xia Y, Duan Q: Study on the improved effect of arachidonic acid on free fatty acid-induced hepatic insulin resistance. China J Pract Chin Modern Med 2005;18:1388-1390.
7. Xia Y, Wang X, Duan Q, Wan X, Qin L: Role of PKC in insulin resistance and study on prevention effect of arachidonic acid. China J Modern Med 2005;15:2746-2749.
8. Vuguin P, Raab E, Liu B, Barzilai N, Simmons R: Hepatic insulin resistance precedes the development of diabetes in a model of intrauterine growth retardation. Metabolism 2004;53:1107-1112.
9. Chun Y, Yin ZD: Glycogen assay for diagnosis of female genital Chlamydia trachomatis infection. J Clin Microbiol 1998;36:1081-1082.
10. Jomain-Baum M, Schramm V: Kinetic mechanism of phosphoenolpyruvate carboxykinase (GTP) from rat liver cytosol. J Biol Chem 253:3648-3659.
11. Chang JC, Wu MC, Liu IM, Cheng JT: Increase of insulin sensitivity by stevioside in fructose-rich chow-fed rats. Horm Metab Res 2005;37:610-616.
12. Kahn BB, Flier JS: Obesity and insulin resistance. J Clin Invest 2000;106:473-481.
13. Wong KC, Wang Z: Prevalence of type 2 diabetes mellitus of Chinese populations in Mainland China, Hong Kong, and Taiwan. Diabetes Res Clin Pract 2006;73:126-134.
14. Hwang IK, Go VL, Harris DM, Yip I, Song MK: Effect of arachidonic acid plus zinc on glucose disposal in genetically diabetic (ob/ob) mice. Diabetes Obes Metabol 2002;4:124-131.
15. Song MK, Hwang IK, Rosenthal MJ, Harris DM, Yamaguchi DT, Yip I, Go V: Antidiabetic action of arachidonic acid and zinc in genetically type 2 diabetic Goto-Kakizaki rats. Metabolism 2003;52:7-12.
16. Nugent C, Prins JB, Whitehead JP, Wentworth JM, Chatterjee VK, O'Rahilly S: Arachidonic acid stimulates glucose uptake in 3T3-L1 adipocytes by increasing GLUT1 and GLUT4 levels at the plasma membrane: evidence for involvement of lipoxygenase metabolites and peroxisome proliferator-activated receptor gamma. J Biol Chem 2001;276:9149-9157.
17. Haugen F, Zahid N, Dalen KT, Hollung K, Nebb HI, Drevon CA: Resistin expression in 3T3-L1 adipocytes is reduced by arachidonic acid. J Lipid Res 2005;46:143-153.
18. Rajala MW, Obici S, Scherer PE, Rossetti L: Adipose-derived resistin and gut-derived resistin-like molecule-β selectively impair insulin action on glucose production. J Clin Invest 2003;111:225-230.
19. Leighton B, Budohoski L, Lozeman FJ, Challiss RA, Newsholme EA: The effect of prostaglandins E1.E2 and F2α and indomethacin on the sensitivity of glycolysis and glycogen synthesis to insulin in the stripped soleus muscle of the rat. Biochem J 1985;227:337-340.
20. Abe K, Ozono Y, Miyazaki M, Furusu A, Shioshita K, Sasaki O, Tsukasaki S, Harada T, Kohno S: prostaglandin E1 for renal papillary necrosis in patient with diabetes mellitus. J Int Med Res 1999;27:90-95.
21. Ezaki O: IIb group metal ions (Zn2+, Cd2+, Hg2+) stimulate glucose transport activity by post-insulin receptor kinase mechanism in rat adipocytes. J Biol Chem 1989;264:16118-16122.
22. Song MK, Littner MR, Adham NF, Kazmi GM, Lott FD: Effect of oral administration of arachidonic acid on prostaglandin and zinc metabolism in plasma and small intestine of the rat. Prostaglandins Leukot Med 1985;17:59-66.
23. Dixon G, Nolan J, McClenaghan NH, Flatt PR, Newsholme P: Arachidonic acid, palmitic acid and glucose are important for the modulation of clonal pancreatic beta-cell insulin secretion, growth and functional integrity. Clin Sci (Lond) 2004;106:191-199.
24. Elks ML: Divergent effects of arachidonate and other free fatty acids on glucose-stimulated insulin release from rat islets. Cell Mol Biol (Noisy-le-grand) 1994;40:761-768.
25. Puljak L, Pagliassotti MJ, Wei Y, Qadri I, Parameswara V, Esser V, Fitz JG, Kilic G: Inhibition of cellular responses to insulin in a rat liver cell line: a role for PKC in insulin resistance. J Physiol 2005;563:471-482.
26. Talukdar I, Szeszel-Fedorowicz W, Salati LM: Arachidonic acid inhibits the insulin induction of glucose-6-phosphate dehydrogenase via p38 MAP kinase. J Biol Chem 2005;280:40660-40667.
27. Zhao W, Xiao J, Yang W, Wang N, Wang X, Chen X, Bu S: Relationship between hepatic insulin resistance and the expression of genes involved in hepatic glucose output. Zhonghua Gan Zang Bing Za Zhi 2006;14:45-48.
28. Altomonte J, Richter A, Harbaran S, Suriawinata J, Nakae J, Thung SN, Meseck M, Accili D, Dong H: Inhibition of Foxo1 function is associated with improved fasting glycemia in diabetic mice. Am J Physiol 2003;285:E718-E728.
29. Marzban L, Rahimian R, Brownsey RW, McNeill JH: Mechanisms by which bis (maltolato) oxovanadium (IV) normalizes phosphoenolpyruvate carboxykinase and glucose-6-phosphatase expression in streptozotocin-diabetic rats in vivo. Endocrinology 2002;143:4636-4645.
30. Bajaj M, Suraamornkul S, Hardies LJ, Pratipanawatr T, DeFronzo RA: Plasma resistin concentration, hepatic fat content, and hepatic and peripheral insulin resistance in pioglitazone-treated type II diabetic patients. Int J Obes Relat Metab Disord 2004;30:783-789.